dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Jean, Francois |
dc.contributor.author | Arsandaux, Julie |
dc.contributor.author | Montagni, Ilaria |
dc.contributor.author | Collet, Ophélie |
dc.contributor.author | Fatséas, Mélina |
dc.contributor.author | Auriacombe, Marc |
dc.contributor.author | Ramos Quiroga, José Antonio |
dc.date.accessioned | 2022-08-12T06:31:20Z |
dc.date.available | 2022-08-12T06:31:20Z |
dc.date.issued | 2022-03-29 |
dc.identifier.citation | Jean FAM, Arsandaux J, Montagni I, Collet O, Fatséas M, Auriacombe M, et al. Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. Eur Psychiatry. 2022 Mar 29;65(1):1–18. |
dc.identifier.issn | 1778-3585 |
dc.identifier.uri | https://hdl.handle.net/11351/7995 |
dc.description | ADHD; Cannabis; Students |
dc.description.abstract | Background
Cannabis use in university students is associated with academic achievement failure and health issues. The objective of the study was to evaluate the association between attention deficit hyperactivity disorder (ADHD) symptoms and cannabis use after 1 year among students according to previous cannabis use.
Methods
Students in France were recruited from February 2013 to July 2020 in the i-Share cohort. 4,270 participants were included (2,135 who never used cannabis at inclusion and 2,135 who did). The Adult ADHD Self-Report Scale (ASRS) was used to assess ADHD symptoms at inclusion. Cannabis use frequency was evaluated 1 year after inclusion. Multinomial regressions were conducted to assess the association between inclusion ADHD symptoms and cannabis use after 1 year.
Results
Increase in ASRS scores was linked with a greater probability to use cannabis after 1 year and to have a higher cannabis use frequency (once a year—once a month adjusted odds ratio [OR]: 1.24 (1.15–1.34), more than once a month adjusted OR: 1.43 (1.27–1.61)). Among participants who never used cannabis at inclusion, this association disappeared (once a year—once a month adjusted OR: 1.15 (0.95–1.39), more than once a month adjusted OR: 1.16 (0.67–2)) but remained in participants who ever used cannabis at inclusion (once a year—once a month adjusted OR: 1.17 (1.06–1.29), more than once a month adjusted OR: 1.35 (1.18–1.55)).
Conclusions
High levels of ADHD symptoms in students could lead to continued cannabis use rather than new initiations. |
dc.language.iso | eng |
dc.publisher | Cambridge University Press |
dc.relation.ispartofseries | European Psychiatry;65(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Estudiants |
dc.subject | Trastorn per dèficit d'atenció amb hiperactivitat |
dc.subject | Abús de substàncies |
dc.subject.mesh | Attention Deficit Disorder with Hyperactivity |
dc.subject.mesh | Marijuana Abuse |
dc.subject.mesh | Students |
dc.title | Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1192/j.eurpsy.2022.14 |
dc.subject.decs | trastornos de déficit de atención con hiperactividad |
dc.subject.decs | abuso de marihuana |
dc.subject.decs | estudiantes |
dc.relation.publishversion | http://dx.doi.org/10.1192/j.eurpsy.2022.14 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Jean FAM] Department of Psychiatry, Dr Jean Eric Techer Hospital, Calais, France. University of Bordeaux, Faculty of Medicine, Bordeaux, France. Bordeaux Population Health Research Center, National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale—INSERM), Bordeaux, France. [Arsandaux J, Montagni I, Collet O] University of Bordeaux, Faculty of Medicine, Bordeaux, France. Bordeaux Population Health Research Center, National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale—INSERM), Bordeaux, France. [Fatséas M] University of Bordeaux, Faculty of Medicine, Bordeaux, France. Charles Perrens Hospital, Bordeaux, France. Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Bordeaux, France. National Center for Scientific Research (Centre national de la recherche scientifique—CNRS), Institut de Neurosciences Cognitives et Intégratives d’Aquitaine (INCIA), Bordeaux, France. [Auriacombe M] University of Bordeaux, Faculty of Medicine, Bordeaux, France. Charles Perrens Hospital, Bordeaux, France. Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Bordeaux, France. National Center for Scientific Research (Centre national de la recherche scientifique—CNRS), Addiction Team/SANPSY, Bordeaux, France. [Ramos-Quiroga JA] Grup de Recerca en Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Psiquiatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain. Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 35348052 |
dc.identifier.wos | 000786370300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |